APA (7th ed.) Citation

Gong, J., Drobni, Z., Silva, T. Q., Zafar, A., Reynolds, K., Gilman, H., . . . Neilan, T. G. (2023). ASSOCIATION OF USE OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS WITH ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS. Journal of the American College of Cardiology (JACC), 81, 2169. https://doi.org/10.1016/S0735-1097(23)02613-X

Chicago Style (17th ed.) Citation

Gong, Jingyi, et al. "ASSOCIATION OF USE OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS WITH ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS." Journal of the American College of Cardiology (JACC) 81 (2023): 2169. https://doi.org/10.1016/S0735-1097(23)02613-X.

MLA (9th ed.) Citation

Gong, Jingyi, et al. "ASSOCIATION OF USE OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS WITH ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS." Journal of the American College of Cardiology (JACC), vol. 81, 2023, p. 2169, https://doi.org/10.1016/S0735-1097(23)02613-X.